Diabetes education and self-management for ongoing and newly diagnosed (DESMOND): Process modelling of pilot study

Research output: Contribution to journalJournal articleResearchpeer-review

Objective: To determine the effects of a structured education program on illness beliefs, quality of life and physical activity in people newly diagnosed with Type 2 diabetes. Methods: Individuals attending a diabetes education and self-management for ongoing and newly diagnosed (DESMOND) program in 12 Primary Care Trusts completed questionnaire booklets assessing illness beliefs and quality of life at baseline and 3-month follow-up, metabolic control being assessed through assay of HbA1c. Results: Two hundred and thirty-six individuals attended the structured self-management education sessions, with 97% and 64% completing baseline and 3-month follow-up questionnaires. At 3 months, individuals were more likely to: understand their diabetes; agree it is a chronic illness; agree it is a serious condition, and that they can affect its course. Individuals achieving a greater reduction in HbA1c over the first 3 months were more likely to agree they could control their diabetes at 3 months (r = 0.24; p = 0.05), and less likely to agree that diabetes would have a major impact on their day to day life (r = 0.35; p = 0.006). Conclusion: Pilot data indicate the DESMOND program for individuals newly diagnosed with Type 2 diabetes changes key illness beliefs and that these changes predict quality of life and metabolic control at 3-month follow-up. Practice implications: Newly diagnosed individuals are open to attending self-management programs and, if the program is theoretically driven, can successfully engage with the true, serious nature of diabetes.

Original languageEnglish
JournalPatient Education and Counseling
Issue number1-3
Pages (from-to)369-377
Number of pages9
Publication statusPublished - 1 Dec 2006

    Research areas

  • Illness beliefs, Newly diagnosed, Patient self-management, Quality of life, Structured education, Type 2 diabetes mellitus

ID: 189877346